Literature DB >> 3063531

Reduced insulin removal and erythrocyte insulin binding in obese children.

M Knip1, P Lautala, R Puukka.   

Abstract

To study the relationship between childhood obesity, weight loss, hyperinsulinaemia and the erythrocyte insulin receptor, we measured the plasma concentrations of immunoreactive insulin (IRI) and C-peptide and the binding of 125I-insulin to erythrocytes in 12 obese children with a mean age +/- SD of 11.4 +/- 2.5 years and a mean relative weight score +/- SD of 4.8 +/- 1.4 and 12 age-matched normal-weight children. Eight obese children were re-evaluated after 1 year's participation in a weight reduction programme. The obese children had higher fasting plasma concentrations of IRI (P less than 0.01) and C-peptide (P less than 0.05) and a lower C-peptide to IRI molar ratio (P less than 0.01) than the normal-weight children. The obese children had in addition a reduced erythrocyte insulin binding (P less than 0.05 or less) over the physiological range of circulating insulin concentration. There was a negative correlation (r = -0.60; P less than 0.01) between the insulin tracer binding and the relative weight. The weight reduction programme resulted in a decrease of 1.0 SD (P less than 0.05) in the mean relative weight score. At the end of the therapy the obese children had lower fasting blood glucose levels (P less than 0.05) and lower plasma IRI concentrations at 90 min (P less than 0.05) after an oral glucose load than at the onset of therapy. There were no significant differences between the insulin binding characteristics at the commencement and at the end of the treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063531     DOI: 10.1007/bf00441410

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  HEIGHTS AND WEIGHTS OF FINNISH CHILDREN AND YOUNG ADULTS.

Authors:  L BAECKSTROEM-JAERVINEN
Journal:  Ann Paediatr Fenn       Date:  1964

2.  Basal insulin secretion and erythrocyte insulin binding in preterm and term newborn infants.

Authors:  M Knip; R Puukka; P Lautala; M Leppilampi; M Puukka
Journal:  Biol Neonate       Date:  1983

3.  An anomaly of insulin removal in perfused livers of obese-hyperglycemic (ob/ob) mice.

Authors:  C Karakash; F Assimacopoulos-Jeannet; B Jeanrenaud
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

4.  Structure of the human erythrocyte insulin receptor.

Authors:  G M Ward; L C Harrison
Journal:  Diabetes       Date:  1986-01       Impact factor: 9.461

5.  Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance.

Authors:  F Grigorescu; J S Flier; C R Kahn
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

6.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

7.  Downregulation of insulin receptors in obese man.

Authors:  J P Wigand; W G Blackard
Journal:  Diabetes       Date:  1979-04       Impact factor: 9.461

8.  Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels.

Authors:  R Rossell; R Gomis; R Casamitjana; R Segura; E Vilardell; F Rivera
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

9.  Comparison of insulin binding to cells of fed and fasted obese patients: results in erythrocytes and monocytes.

Authors:  R G Spanheimer; R S Bar; B H Ginsberg; M L Peacock; I Martino
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

10.  Circadian profiles of insulin receptors in insulin-dependent diabetics in usual and poor metabolic control.

Authors:  O Pedersen; E Hjøllund; H O Lindskov; H Beck-Nielsen; J Jensen
Journal:  Am J Physiol       Date:  1982-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.